Ayala Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Corporate Update
Provided By Globe Newswire
Last update: May 23, 2023
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced first-quarter 2023 financial results and provided a corporate update.
